Results 21 to 30 of about 493,772 (158)

Paraneoplastic Diseases of the Central Nervous System [version 1; peer review: 2 approved]

open access: yesF1000Research, 2020
Paraneoplastic neurological syndromes are nonmetastatic complications of malignancy secondary to immune-mediated neuronal dysfunction or death. Pathogenesis may occur from cell surface binding of antineuronal antibodies leading to dysfunction of the ...
Jonathan Galli, John Greenlee
doaj   +1 more source

Cerebellar long-term depression and auto-immune target of auto-antibodies: the concept of LTDpathies

open access: yesMolecular Biomedicine, 2021
There is general agreement that auto-antibodies against ion channels and synaptic machinery proteins can induce limbic encephalitis. In immune-mediated cerebellar ataxias (IMCAs), various synaptic proteins, such as GAD65, voltage-gated Ca channel (VGCC),
Hiroshi Mitoma   +3 more
doaj   +1 more source

Immune checkpoint inhibitor neurotoxicity: long-term outcomes with focus on 1-year neurological sequelae

open access: yesJournal for ImmunoTherapy of Cancer
Background Data on the long-term course of neurological immune-related adverse events (n-irAEs) are limited by the size of studies as well as short and heterogeneous follow-up durations.
Dimitri Psimaras   +13 more
doaj   +1 more source

Antibodies to TRIM46 are associated with paraneoplastic neurological syndromes. [PDF]

open access: yesAnn Clin Transl Neurol, 2017
Paraneoplastic neurological syndromes (PNS) are often characterized by the presence of antineuronal antibodies in patient serum or cerebrospinal fluid.
van Coevorden-Hameete MH   +12 more
europepmc   +3 more sources

Comparison of commercial and in-house tissue-based and cell-based assays for the detection of autoantibodies targeting neuronal surface proteins: a prospective cohort study

open access: yesFrontiers in Immunology
IntroductionThe detection of antibodies targeting neuronal antigens is a keystone for the diagnosis of autoimmune encephalitis (AE) and paraneoplastic neurological syndromes (PNS).
David Goncalves   +17 more
doaj   +1 more source

Paraneoplastic antigens as biomarkers for early diagnosis of ovarian cancer

open access: yesGynecologic Oncology Reports, 2017
Paraneoplastic syndromes are a group of rare disorders that can be triggered by an abnormal immune response to proteins from tumors of the lung, ovary, lymphatics, or breast. Paraneoplastic clinical syndromes affect
Madhumita Chatterjee   +2 more
doaj   +1 more source

Neurological paraneoplastic syndromes.

open access: yes, 1997
Paraneoplastic neurological syndromes are uncommon, however, their diagnosis is of major practical importance. The identification of antibodies in the serum or cerebrospinal fluid in central nervous system paraneoplastic syndromes confirms the clinical ...
Grant, R, Nath, U
core   +1 more source

Psychiatric manifestations of paraneoplastic syndromes

open access: yesEuropean Psychiatry, 2022
Introduction Paraneoplastic syndromes (PS) result from indirect effects of neoplasms. In 50% of the cases the symptoms precede the diagnosis and run independently.
M. Lemos, A. Lourenço, M. Ribeiro
doaj   +1 more source

A rare case of concomitant Lambert–Eaton myasthenic syndrome and syndrome of inappropriate antidiuretic hormone secretion in a patient with small cell lung carcinoma

open access: yesRespiratory Medicine Case Reports, 2023
Small cell lung carcinoma (SCLC) is a neuroendocrine carcinoma with a poor prognosis and is a common cause of paraneoplastic syndromes. Paraneoplastic syndromes are characterized by neurological and endocrinological problems in patients with malignancy ...
Yasuharu Oda   +9 more
doaj   +1 more source

Autonomic paraneoplastic neurological syndromes

open access: yes, 2007
Autonomic paraneoplastic neurological syndromes (PNS) typically present as chronic gastrointestinal pseudo-obstruction or orthostatic hypotension and usually occur in association with other PNS rather than in isolation.
HART IK   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy